Re-entry HAPE is a particular form of high-altitude pulmonary edema in people who live permanently at high altitude (La Paz 3600 m, Cuzco 3400 m, Leh 3500 m residents) and return after 2–6 weeks at low altitude. Mechanism: temporary loss of hypoxia tolerance makes return to home altitude trigger HAPE like in a non-acclimatized tourist. A phenomenon less known among trekkers but crucial for Sherpas, Peruvian guides, and Nepalese climatologists.
In a nutshell — Re-entry HAPE
- Who: residents of altitude >2500 m returning after >2 weeks at <1500 m
- When: 24–72 h after returning to home altitude
- Risk: 1–3% in children, <0.5% in adults
- Mechanism: loss of hypoxic pulmonary vasoconstriction (HPV) reaction and partial loss of polycythemia
- Prophylaxis: nifedipine XL 30 mg 1×/day for the first 5 days after return
- Difference from classic HAPE: in an “autochthonous” person — already genetically and adaptively acclimatized
Re-entry HAPE mechanism
1. Loss of HPV response (within weeks)
Hypoxic pulmonary vasoconstriction (HPV) in altitude residents is gradually “trained” to a milder response. After moving to the lowlands (oxygen-rich), HPV fades within 1–3 weeks. Return to 3500 m triggers a strong, non-physiological HPV reaction — pulmonary arterial constriction, uneven perfusion, alveolar edema.
2. Loss of polycythemia
A La Paz resident typically has hematocrit 55–60% — better oxygen binding. After 2–4 weeks in the lowlands, hematocrit drops to 45–50%. Return to altitude = sudden tissue oxygen deficit, forced hemodynamic and ventilatory compensation.
3. Children particularly at risk
Children 2–12 years old lose adaptation faster than adults (greater regulatory variability). After a lowland vacation, children from La Paz have 1–3% re-entry HAPE risk. Peruvian pediatrics has recommended nifedipine prophylaxis for children returning after a break for 30 years.
Prophylaxis — nifedipine protocol
- Nifedipine XL/retard 30 mg 1× daily morning
- Start: 24 h before returning to altitude
- Duration: 5 days after return (or until full readaptation)
- Alternative: amlodipine 5–10 mg 1× daily (longer half-life)
- Salmeterol (inhaler 125 μg 2× daily) — alternative or adjunct for patients with hypertension
- Nifedipine side effects: initial headaches (2–3 days), ankle edema, facial flushing
I am not a great enthusiast of drug prophylaxis, because it gets overused — some climbers take these medicines like sweets. At base camp, though, I had a participant who acclimatized unusually slowly and had suffered high-altitude cerebral edema in the past. In his case the medication was justified and it worked: he acclimatized and continued the trek. That is the difference between prophylaxis based on a history of illness and prophylaxis just in case.
Who should consider prophylaxis
- Sherpa returning after 3 weeks vacation in Kathmandu (1400 m) to trek with client from EBC (5364 m)
- Andean guide returning after 1-month break
- Children from autochthonous families La Paz / Potosí returning from coastal vacation
- Cuzco physician returning after 2-week conference in Lima
- People with HAPE-susceptible phenotype (prior HAPE episodes)
Symptoms and treatment
Symptoms identical to classic HAPE: resting dyspnea, cough (later pink/bloody), weakness, cyanosis, SpO₂ drops 10–15% below norm for altitude. Time of onset: 24–72 h after return. Treatment:
- Oxygen (2–4 L/min via mask) — most important first step
- Immediate nifedipine 20 mg sublingual + 30 mg XL every 12 h
- Sitting position (eases breathing)
- Descent to 2000–2500 m if possible (rarely needed — re-entry HAPE responds well to oxygen + nifedipine)
- Dexamethasone 4 mg every 6 h if accompanying HACE symptoms
- Evacuation if no response in 2 h or SpO₂ <70% with oxygen
Frequently asked questions
After how many weeks in lowlands does an altitude dweller lose acclimatization?
Evolutionary process: after 2 weeks in lowlands HPV (hypoxic pulmonary vasoconstriction) is already significantly ‘switched off’, after 4-6 weeks returns to values of a non-altitude-adapted person. Polycythemia (hematocrit) drops slower: 3-4% per week (from 58% to 50% in 4 weeks). Mitochondrial adaptation (muscle mitochondrial density) drops in 2-3 months. Conclusion: return after 6 weeks treat yourself as ‘outside’ tourist.
Do I need nifedipine returning from Kathmandu vacation?
Depends on where you’re returning from and how long in lowlands. Sherpa returning from Kathmandu (1400 m) after 3 weeks to trek with client at EBC (5364 m) – yes, nifedipine XL 30 mg prophylaxis for 5 days is recommended. But Sherpa returning after 3 days lowland to trek in Namche (3440 m) – not necessary, altitude difference small, time short. Rule: difference >2000 m altitude + stay >2 weeks in lowlands = prophylaxis.
Can re-entry HAPE happen to an adult?
Yes, but more rarely than in children. Statistics: 0.3-0.5% adults returning to altitude after 2+ weeks vs 1-3% children 2-12 years. Men >women (higher muscle mass = higher oxygen demand). Adult with prior HAPE (HAPE-susceptible) has re-entry risk of 5-15% – prophylaxis mandatory for them. Genetics: residents with ACE I/I variant are more susceptible.
Is nifedipine XL available OTC in Peru/Bolivia/Nepal?
Yes, in high-altitude countries Andes and Himalayas nifedipine is available without prescription in pharmacies (paradoxically easier than in Europe/USA). Peru: nifedipine XL 30 mg ~$10 per month course. Nepal: ~$8-12. Bolivia: ~$5-8. Note: check expiration and packaging integrity – some pharmacies keep old drugs in bad climate conditions. Better approach: bring from Europe/USA as prophylaxis, buy locally only as rescue/backup.
Salmeterol instead of nifedipine – when?
Salmeterol (inhaler 125 μg 2x/day) is an alternative for patients who: 1) have controlled hypertension on beta-blocker (nifedipine may interfere); 2) have orthostatic hypotension (ankle edema and BP drop on nifedipine); 3) don’t tolerate oral prophylaxis (GI symptoms). Salmeterol acts directly in lungs, fewer systemic effects. Dose: 125 μg 2x/day from return day for 5 days. Available in most countries without prescription. Cost: $30-50 per inhaler (small dose covers 3-4 courses).
References
- Hultgren HN, Marticorena EA. High altitude pulmonary edema. Epidemiologic observations in Peru. Chest. 1978;74(4):372–376.
- Bärtsch P, Mairbäurl H, Maggiorini M, Swenson ER. Physiological aspects of high-altitude pulmonary edema. J Appl Physiol. 2005;98(3):1101–1110.
- Scherrer U, Rexhaj E, Jayet PY, et al. New insights in the pathogenesis of high-altitude pulmonary edema. Prog Cardiovasc Dis. 2010;52(6):485–492.
- Luks AM et al. Wilderness Medical Society Clinical Practice Guidelines 2019.
Note: Re-entry HAPE is particularly relevant for high-altitude residents (Sherpas, Andean guides) and their families. For typical trekkers less relevant, but important for understanding physiology. Consultation with mountain medicine physician recommended 2-4 weeks before returning to altitude.